Canada health officials are investigating the deaths of two plasma donors in Winnipeg, Manitoba

Reported by: Oahimire Omone Precious | Edited by: Oravbiere Osayomore Promise.

Canada health officials are investigating the deaths of two plasma donors in Winnipeg, Manitoba, raising concerns about the safety of paid plasma collection as authorities seek to determine whether the fatalities are linked to the donation process. The incidents, which occurred months apart, are now under review by federal regulators as part of a broader examination of procedures and safety protocols at privately operated plasma collection centres in the city.

Health Canada confirmed that it received reports of two fatal adverse events involving individuals who had recently donated plasma at facilities operated by the Spanish healthcare company Grifols. The first death occurred in October 2025, while the second was reported on January 30, 2026. Both incidents happened after the individuals donated plasma at for-profit collection centres in Winnipeg that compensate donors for their contributions.

One of the deceased donors has been identified as Rodiyat Alabede, a 22-year-old international student with ties to Nigeria and Ivory Coast. Friends described her as determined and compassionate, noting that she had pursued her studies abroad with a strong sense of purpose and resilience. The identity of the second donor has not been publicly released, in line with privacy regulations governing health investigations in Canada.

Health Canada officials say they are currently assessing whether the deaths were connected to the plasma donation procedures or whether they resulted from unrelated medical conditions or other factors. The federal agency has dispatched inspectors to review the operations of the clinics involved and to examine records related to the procedures carried out before the incidents occurred.

In a statement, Grifols said it reported the deaths to regulators as required and has launched its own internal review. The company emphasized that it has no evidence at this stage to suggest that the plasma donation process caused the fatalities. According to the company, plasma donation is generally considered safe when conducted under regulated medical protocols, and millions of donations are performed worldwide each year without serious complications.

Despite these assurances, the incidents have reignited debate in Canada over the use of paid plasma donation systems. Unlike traditional blood donations, which in Canada are largely voluntary and unpaid, some plasma collection centres offer financial compensation to donors. Payments can reach around 100 Canadian dollars per visit, with additional incentives offered for frequent donations.

Critics argue that financial incentives may encourage economically vulnerable individuals, including students and low-income residents, to donate plasma more frequently than they otherwise would. Advocacy groups have also raised ethical concerns about the expansion of for-profit plasma clinics in the country, warning that the model could undermine the voluntary blood donation system established after Canada’s tainted blood crisis of the 1980s.

That scandal, which resulted in thousands of Canadians contracting HIV and hepatitis C from contaminated blood products, led to sweeping reforms in the country’s blood supply system. Following a federal inquiry, Canada adopted a largely non-profit model for blood collection and implemented strict oversight to prevent similar tragedies.

However, the growing demand for plasma-derived medicines has pushed authorities to explore new ways of securing supply. Plasma is used to produce critical treatments, including immunoglobulins and therapies for rare diseases, immune disorders, and certain neurological conditions. Canada currently relies heavily on imported plasma products, particularly from the United States, where paid plasma donation is widespread.

Supporters of the current system argue that compensated plasma donation can help address shortages of life-saving medicines while maintaining strict safety standards. They note that every donation undergoes screening and that donors must meet health requirements before participating.

Medical experts emphasize that severe reactions to plasma donation are extremely rare. Typical side effects include dizziness, fatigue, or fainting, which usually resolve quickly. Deaths linked directly to plasma donation procedures are considered exceptionally uncommon, prompting investigators to carefully examine whether other health conditions or external factors may have contributed to the recent fatalities.

Health Canada has indicated that it will continue to review the circumstances surrounding both deaths, including medical histories, procedural records, and clinic safety measures. Regulators have also stressed that any death occurring shortly after a donation must be reported and investigated, regardless of whether the donation itself is believed to be responsible.

The investigation’s outcome could influence future regulation of the plasma donation industry in Canada. If safety concerns are confirmed, authorities may introduce stricter oversight or modify guidelines governing donation frequency, donor screening, or compensation practices.

For now, federal health officials are urging caution against drawing conclusions until the investigation is complete. Families of the deceased donors have been offered support, while regulators continue to examine the events that led to the tragic incidents.

As scrutiny intensifies, the case has become a focal point in Canada’s ongoing debate about balancing medical demand for plasma-based therapies with ethical and safety considerations surrounding paid donation systems.

📩 Stone Reporters News | 🌍 stonereportersnews.com
✉️ info@stonereportersnews.com | 📘 Facebook: Stone Reporters | 🐦 X (Twitter): @StoneReportNew | 📸 Instagram: @stonereportersnews